Gender differences in the association between C-reactive protein, lung function impairment, and COPD

References

• [Anon]1983Standardisation of lung function tests. European community for Coal SteelClin Respir Phys19Suppl 5227
   Google Scholar
• [Anon]1995Standardization of spirometry, 1994 update. American Thoracic SocietyAm J Respir Crit Care Med1521107367663792
   PubMed Web of Science ®Google Scholar
• [Anon]2002The European Community Respiratory Health Survey II. The European Community Resiratory Health Survey II Steering CommitteeEur Respir J201071912449157
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJE2002Smoking and lung function of Lung Health Study participants after 11 yearsAm J Respir Crit Care Med166675912204864
   PubMed Web of Science ®Google Scholar
• BarnesPJ2000Chronic obstructive pulmonary diseaseN Engl J Med3432698010911010
   PubMed Web of Science ®Google Scholar
• BroekhuizenRWoutersEF2006Raised CRP levels mark metabolic and functional impairment in advanced COPDThorax61172216055618
   PubMed Web of Science ®Google Scholar
• BurchfielCMMarcusEB1995Effects of smoking and smoking cessation on longitudinal decline in pulmonary functionAm J Respir Crit Care Med1511778857767520
   PubMed Web of Science ®Google Scholar
• BurchfielCMMarcusEB1996Characteristics associated with rapid decline in forced expiratory volumeAnn Epidemiol6217278827157
   PubMed Web of Science ®Google Scholar
• BurneyPGLuczynskaC1994The European Community Respiratory Health SurveyEur Respir J7954608050554
   PubMed Web of Science ®Google Scholar
• ChinnDJCotesJE1996Longitudinal effects of change in body mass on measurements of ventilatory capacityThorax516997048882076
   PubMed Web of Science ®Google Scholar
• ChinnSJarvisD2005Smoking cessation: maximum benefit for lung function requires control of weight gainLancet36516293515885295
   PubMed Web of Science ®Google Scholar
• DahlMTybjaerg-HansenA2001Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16410081111587987
   PubMed Web of Science ®Google Scholar
• DaneshJWheelerJG2004C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart diseaseN Engl J Med35013879715070788
   PubMed Web of Science ®Google Scholar
• de MarcoRAccordiniS2004An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesThorax59120514760151
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTA2002Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax578475212324669
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTA2005Airway and systemic inflammation and decline in lung function in patients with COPDChest1281995200416236847
   PubMed Web of Science ®Google Scholar
• FrohlichMSundM2003Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95)Eur Heart J2413657212871694
   PubMed Web of Science ®Google Scholar
• GanWQManSF2005The interactions between cigarette smoking and reduced lung function on systemic inflammationChest1275586415705996
   PubMed Web of Science ®Google Scholar
• GanWQManSFP2004Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax5957458015223864
   PubMed Web of Science ®Google Scholar
• HershCPMillerDT2006Genetic determinants of C-reactive protein in COPDEur Respir J2811566216971405
   PubMed Web of Science ®Google Scholar
• HurstJRWilkinsonTM2005Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPDChest12712192615821198
   PubMed Web of Science ®Google Scholar
• JonesPWAgustiAG2006Outcomes and markers in the assessment of chronic obstructive pulmonary diseaseEur Respir J278223216585091
   PubMed Web of Science ®Google Scholar
• LangePGrothS1989Effects of smoking and changes in smoking habits on the decline of FEV1Eur Respir J2811162806504
   PubMed Web of Science ®Google Scholar
• MacyEMHayesTE1997Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applicationsClin Chem435288990222
   PubMed Web of Science ®Google Scholar
• ManSFPConnettJE2006C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary diseaseThorax618495316738034
   PubMed Web of Science ®Google Scholar
• ManninoDMFordES2003Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition ExaminationAm J Med1147586212829203
   PubMed Web of Science ®Google Scholar
• MurrayCJLLopezAD1996Evidence-based health policy: lessons from the Global Burden of Health StudyScience27474038966556
   PubMed Web of Science ®Google Scholar
• OckeneISMatthewsCE2001Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adultsClin Chem474445011238295
   PubMed Web of Science ®Google Scholar
• ÓlafsdóttirIGíslasonT2005C-reactive protein is elevated in non-allergic but not allergic asthma – a multicentre epidemiological studyThorax60451415923243
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistAS2001Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summaryRespir Care4679882511463370
   PubMedGoogle Scholar
• PepysMBHirschfieldGM2003C-reactive protein: a critical updateJ Clin Invest11118051212813013
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMullerovaH2006C-reactive protein in patients with COPD, control smokers and non-smokersThorax6123816143583
   PubMed Web of Science ®Google Scholar
• RidkerPMCannonCP2005C-reactive protein levels and outcomes after statin therapyN Engl J Med35220815635109
   PubMed Web of Science ®Google Scholar
• ShaabanRKonyS2006Change in C-reactive protein levels and FEV(1) decline: a longitudinal population-based studyRespir Med Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• SinDDLacyP2004Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med170760515229100
   PubMed Web of Science ®Google Scholar
• TamakoshiKYatsuyaH2003Long-term body weight variability is associated with elevated C-reactive protein independent of current body mass index among Japanese menInt J Obes Relat Metab Disord2710596512917711
   PubMed Web of Science ®Google Scholar
• TownsendMCDuCheneAG1991Pulmonary function in relation to cigarette smoking and smoking cessation. MRFIT Research GroupPrev Med20621371758842
   PubMed Web of Science ®Google Scholar
• WangMLMcCabeL1997Weight gain and longitudinal changes in lung function in steel workersChest1111526329187168
   PubMed Web of Science ®Google Scholar
• WilkinsJGallimoreJR1998Rapid automated high sensitivity enzyme immunoassay of C-reactive proteinClin Chem44(6 Pt 1)1358619625071
   PubMed Web of Science ®Google Scholar
• WilkinsonTMPatelIS2003Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1671090512684248
   PubMed Web of Science ®Google Scholar
• VisserMBouterLM1999Elevated C-reactive protein levels in overweight and obese adultsJAMA2822131510591334
   PubMed Web of Science ®Google Scholar
• WoutersEF2005Local and systemic inflammation in chronic obstructive pulmonary diseaseProc Am Thorac Soc2263316113466
   PubMedGoogle Scholar
• XuXWeissST1994Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differencesEur Respir J71056617925873
   PubMed Web of Science ®Google Scholar